Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINHALATIONStandard

INOMAX

NITRIC OXIDE

Standard Dose
4880PPM
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Prescription
Summary

Approval overview INOMAX is listed in Drugs@FDA under application 020845 (NDA).

Review priority: N/A Marketing status: Prescription Active ingredient NITRIC OXIDE Form and strength GAS;INHALATION - 4880PPM Sponsor MALLINCKRODT IRELAND Submission history Latest submission status date: 2023-01-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview INOMAX is listed in Drugs@FDA under application 020845 (NDA). Review priority: N/A Marketing status: Prescription Active ingredient NITRIC OXIDE Form and strength GAS;INHALATION - 4880PPM Sponsor MALLINCKRODT IRELAND Submission history Latest submission status date: 2023-01-17 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: N/A

Interaction Notes

  • No interaction notes stored yet.